NCI grants SBIR grant to Eutropics for BH3 profiling assay development
The assay, which provides a biomarker/ diagnostic to know the use of approved therapies for multiple cancer indications, is used as a personalized medicinal treatment in Acute Myelogenous
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.